2026 NPPES data Foot & Ankle Surgery Podiatrist NPI 1003294950
Verify on CMS →

CHESTER KLIMEK

Foot & Ankle Surgery Podiatrist in WALLINGTON, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
221
Medicare Part D claims · 94 beneficiaries · Foot & Ankle Surgery Podiatrist avg: 309
Generic prescribing
87%
generic claims · 13% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$722.3
9 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

CHESTER KLIMEK filed 221 Medicare Part D claims in 2023 as a Foot & Ankle Surgery Podiatrist in WALLINGTON, New Jersey, prescribing 87% generic.

221
Part D claims, 2023
87%
generic prescribing
$722.3
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

CHESTER KLIMEK's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

221 49th percentile higher than 49% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). This entry sits in this band. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about CHESTER KLIMEK?

Quality data not reported

NPI registry status

Active

Issued 05/12/2015

NPI 1003294950

Primary specialty

Foot & Ankle Surgery Podiatrist

Mid-sized

8,920 US NPIs in this specialty

Medicare Part D claims

221 28% vs specialty avg

2023 prescription claims

Specialty avg: 309

Specialty distribution in New Jersey

How Foot & Ankle Surgery Podiatrist compares to other specialties among New Jersey providers

New Jersey providers

Foot & Ankle Surgery Podiatrist share within New Jersey

1. Foot & Ankle Surgery Podiatrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Foot & Ankle Surgery Podiatrist share within New Jersey

Specialty board-certification context

Estimated specialty board-certified rate — Foot & Ankle Surgery Podiatrist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Foot & Ankle Surgery Podiatrist ABMS/AOA estimate

Est. board-certified rate (Foot & Ankle Surgery Podiatrist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Foot & Ankle Surgery Podiatrist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

CHESTER KLIMEK appears in the CMS NPPES registry as a Foot & Ankle Surgery Podiatrist provider at 379 MAIN AVE STE 3, WALLINGTON, NJ, 07057, with a listed phone of (201) 655-6617. NPI 1003294950 was issued on 05/12/2015. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KLIMEK most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 221 prescription claims written by this provider, covering 94 Medicare beneficiaries and totaling roughly $32K in drug spend, split 13% brand-name and 87% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Foot & Ankle Surgery Podiatrist is a mid-sized specialty nationwide, with 8,920 enrolled providers across 53 states and an average of 309 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

379 MAIN AVE STE 3
WALLINGTON, NJ 07057

Provider Details

NPI 1003294950
Specialty Foot & Ankle Surgery Podiatrist
Gender Male
NPI Issued 05/12/2015

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for CHESTER KLIMEK. Source: openpaymentsdata.cms.gov.

Total received

$722

Largest payer

Stryker Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

CHESTER KLIMEK — brand share 13.0%
Specialty average (est.)

13% brand-name claims vs 87% generic, on 221 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

221
Total Claims
$32K
Total Drug Cost
94
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
229
Total Day Supply
5,093
Brand vs Generic
13% brand / 87% generic
Brand Drug Cost
$27K
Generic Drug Cost
$5K

Patient Demographics

Average Patient Age
76.9 years
Avg HCC Risk Score
1.59
Gender Split
61% female / 39% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What CHESTER KLIMEK prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Mupirocin
79
Erythromycin
Erythromycin Base In Ethanol
65
Jublia
Efinaconazole
26
Clotrimazole-Betamethasone
Clotrimazole/Betamethasone Dip
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Foot & Ankle Surgery Podiatrist Overview

How CHESTER KLIMEK fits within the Foot & Ankle Surgery Podiatrist landscape nationally.

8,920
Foot & Ankle Surgery Podiatrist Providers in US
53
States with Foot & Ankle Surgery Podiatrist
309
Avg Claims per Provider

CHESTER KLIMEK's 221 claims are below the specialty average of 309.

Nearby Foot & Ankle Surgery Podiatrist Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as KLIMEK.

Compare Foot & Ankle Surgery Podiatrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is CHESTER KLIMEK's specialty?
CHESTER KLIMEK specializes in Foot & Ankle Surgery Podiatrist and practices in WALLINGTON, New Jersey.
How much does CHESTER KLIMEK prescribe under Medicare Part D?
In 2023, CHESTER KLIMEK wrote 221 Medicare Part D claims totaling $32K in drug costs for 94 beneficiaries.
Where is CHESTER KLIMEK located?
CHESTER KLIMEK is located at 379 MAIN AVE STE 3, WALLINGTON, NJ, 07057. Phone: (201) 655-6617.
What is CHESTER KLIMEK's NPI number?
CHESTER KLIMEK's National Provider Identifier (NPI) is 1003294950, issued on 05/12/2015.
Does CHESTER KLIMEK prescribe more brand-name or generic drugs?
CHESTER KLIMEK's prescribing is 13% brand-name and 87% generic drugs by claim count, with $27K in brand drug costs.
How many Foot & Ankle Surgery Podiatrist providers are there in the US?
There are 8,920 Foot & Ankle Surgery Podiatrist providers across 53 states in the US. The average Foot & Ankle Surgery Podiatrist provider writes 309 Medicare Part D claims per year.
What drugs does CHESTER KLIMEK prescribe most often?
Based on 2023 Medicare Part D data, CHESTER KLIMEK's most frequently prescribed drugs include Mupirocin, Erythromycin, Jublia. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does CHESTER KLIMEK accept Medicare?
CHESTER KLIMEK appears in CMS Medicare data with 221 Part D claims and 94 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify CHESTER KLIMEK's credentials?
CHESTER KLIMEK's NPI is 1003294950. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology